Poisons Board warns against misuse of Ozempic for weight loss
Health & Science
By
Ronald Kipruto
| Aug 19, 2025
Pharmacy and Poisons Board CEO Fred Siyoi. [File, Standard]
The Pharmacy and Poisons Board (PPB) has cautioned the public against using semaglutide, commonly sold as Ozempic, for weight loss.
In a statement on Tuesday, August 19, Chief Executive Officer Fred Siyoi said the drug is a prescription-only medicine approved for treating type 2 diabetes, but its misuse for cosmetic purposes is rising.
“The Board wishes to bring to the attention of the public that semaglutide is a Prescription-Only Medicine, and its unsupervised or off-label use may result in serious health outcomes,” said Siyoi.
The Board, mandated to regulate the quality, safety, and distribution of drugs, health products, and technologies in Kenya, also highlighted possible side effects.
READ MORE
New KMA directive on seafarer training gets industry backing
Funding woes scuttle key Seafarers Council's work
Developers condemn reports that most city buildings are unsafe
Win for Kenya as AGOA agreement extended for 3 years
Leases, looting and a grounded fleet expose turbulence at KQ
How Kenya can turn technological progress into real development
Kenya wins three-year AGOA extension, securing jobs
When trust is what it takes to make good profit
Unlocking Kenya's next phase of growth through powering SMEs
Why Telegram remains most restricted social media platform globally
They include low blood sugar (hypoglycemia), eye conditions, acid reflux, and intestinal obstruction, which can range from mild to severe.
“While the benefits of Semagluude outweigh its risks, serious safety concerns continue to be raised,” he added.
The Pharmacy Board has urged the public to avoid misuse of the drug and to report any suspected side effects or poor-quality products.
The warning follows a growing trend in the country, including by social media influencers and marketing firms, that are now promoting semaglutide as a shortcut to weight loss, without informing the masses of the side effects.